• Anlotinib Hydrochloride: Advancing Translational Angiogenesi

  2026-07-23

  This thought-leadership article explores the mechanistic depth and strategic value of Anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor for anti-angiogenic cancer research. Integrating evidence from recent peer-reviewed studies and translational workflows, the article provides actionable guidance for researchers focused on endothelial cell migration inhibition, capillary tube formation assays, and ERK signaling pathway modulation. It also benchmarks Anlotinib against legacy agents and positions APExBIO’s offering as a gold standard in angiogenesis research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-07-23

  This study systematically examines the prevalence, genetic context, and transmission efficiency of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, between 2022 and 2024. Its findings highlight the predominance of plasmid-borne blaNDM-1, extensive multidrug resistance, and highly efficient gene transfer, providing critical insight for infection control and Gram-negative bacterial infection research.

• Tankyrase Inhibition Suppresses HCC via Hippo Pathway Modula

  2026-07-22

  Jia et al. (2017) demonstrated that tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell proliferation by modulating the Hippo signaling cascade. Their work reveals that tankyrase inhibition leads to YAP downregulation and AMOTL1/2 stabilization, indicating a promising therapeutic mechanism beyond Wnt/β-catenin pathway targeting.

• TBK1 Inhibition Mitigates Painful Diabetic Neuropathy via Mi

  2026-07-22

  This study identifies TANK-binding kinase 1 (TBK1) as a central mediator of painful diabetic neuropathy (PDN) through activation of microglial pyroptosis. By targeting TBK1, researchers demonstrated significant alleviation of neuropathic pain in diabetic mouse models, providing a mechanistically precise target for future intervention strategies in diabetes complications.

• In-Vitro Activity of Temafloxacin Against Gram-Positive Bact

  2026-07-21

  This article reviews the pivotal study evaluating temafloxacin’s in-vitro efficacy against Gram-positive cocci, highlighting its superior activity compared to other fluoroquinolones. Key findings inform both antibacterial agent selection and protocol design for research on Gram-positive infections.

• Nystatin (Fungicidin): Mechanism-Driven Antifungal Innovatio

  2026-07-21

  This thought-leadership article guides translational researchers through the latest mechanistic and strategic frontiers in antifungal innovation with Nystatin (Fungicidin), spotlighting its unique ergosterol-binding mechanism, validated efficacy against Candida and Aspergillus, and protocol nuances. Anchored by recent mechanistic studies and critical analyses of antifungal resistance, the article bridges foundational insight with actionable guidance, situates APExBIO's Nystatin as a research benchmark, and highlights how this narrative extends well beyond conventional product literature.

• PD0325901: Advanced MEK Inhibitor Workflows for Cancer Resea

  2026-07-20

  PD0325901 is redefining MEK inhibition with robust, tunable control over cell cycle arrest and apoptosis in cancer research models. This article delivers actionable workflow enhancements, troubleshooting strategies, and translational insights to help researchers maximize data reliability and experimental impact.

• Central Pathways in Opioid-Induced Mechanical Hypersensitivi

  2026-07-20

  This study reveals a brain-to-spinal opioid circuit controlling morphine-induced mechanical hypersensitivity and tolerance in mice. By delineating specific neuronal pathways, the research advances understanding of central mechanisms underlying opioid side effects and points to potential targets for mitigating pain and tolerance.

• PK/PD Evaluation of Gamithromycin Against Rabbit Pasteurello

  2026-07-19

  Wei et al. provide the first comprehensive PK/PD analysis of gamithromycin for the treatment of Pasteurella multocida in rabbits. The study establishes exposure–effect relationships and practical dosing targets, supporting antibiotic optimization in veterinary infection models.

• Chemerin-Driven Sympathetic Activation in the cNTS: Mechanis

  2026-07-18

  This study delineates how chemerin in the caudal nucleus tractus solitarius (cNTS) elevates sympathetic outflow and blood pressure via CMKLR1-mediated superoxide production, independent of AMPA/kainate glutamatergic signaling. The findings clarify receptor-specific pathways in central autonomic regulation, refining the mechanistic understanding crucial for translational neurocardiology research.

• Fingolimod (FTY720) in Cell Assays: Reliable Workflows & Dat

  2026-07-17

  This article explores how Fingolimod (FTY720) (SKU A8548) addresses real laboratory challenges in cell viability and cytotoxicity assays. By grounding protocol optimizations and reagent selection in peer-reviewed benchmarks, we demonstrate why this compound is a trusted solution for sensitive, reproducible immunomodulation and neuroprotection studies.

• Quorum Sensing Rewiring Regulates Antifungal Factors in Lyso

  2026-07-17

  This study reveals a novel, cyclic-di-GMP-independent regulatory mode of antifungal weapon production in Lysobacter, mediated through the interaction of RpfG with hybrid two-component system proteins. The findings expand our understanding of protein phosphorylation signaling in soil bacteria and provide new perspectives for protein phosphorylation analysis in microbial competition.

• Mouse Tissue Lysis Kit (K1038): Protocol and QC Best Practic

  2026-07-16

  The Mouse Tissue Lysis Kit (K1038) provides a streamlined method for lysing mouse tissues for direct use in PCR-based genotyping assays, eliminating the need for conventional DNA extraction steps. It is intended for molecular biology research, not for diagnostic or clinical applications. Researchers benefit from reduced handling time and simplified workflows, but should follow protocol details and limitations closely.

• Telmisartan in Cardiovascular Research: Applied Workflows &

  2026-07-16

  Telmisartan stands out as a precision angiotensin II receptor antagonist for dissecting complex cardiovascular pathways, enabling reproducible modeling of cardiac hypertrophy and hypertension. Explore robust protocol enhancements, data-driven troubleshooting, and how new mechanistic insights from RIP3/CaMKII axis studies shape next-generation assay design.

• Pertussis Toxin: Strategic Immune Modulation in Translationa

  2026-07-15

  This thought-leadership article explores the mechanistic underpinnings and translational utility of Pertussis toxin as an AB5-type protein exotoxin, focusing on immune response modulation in dendritic cells and signal transduction pathways relevant to autoimmune and vaccine research. It provides actionable protocol parameters, dissects the competitive landscape, and offers a visionary outlook for researchers seeking to elevate the reliability and impact of their immunological models.

446 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page